BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 32105171)

  • 1. The Reemergence of Specialty Pharmacy.
    Vanscoy G; Seymore B; Kohli N; Patel J; Ogurchak J
    J Manag Care Spec Pharm; 2020 Mar; 26(3):234-235. PubMed ID: 32105171
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Letter--A Challenge to the Pharmacy Profession to Raise Its Voice on Health Care Reform.
    Rubinstein E
    J Manag Care Spec Pharm; 2017 Dec; 23(12):1277. PubMed ID: 29172982
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Managed Care Pharmacy Research on Inappropriate Opioid Use Interventions.
    Hertzog LL; McAdam-Marx C; Happe LE
    J Manag Care Spec Pharm; 2020 Oct; 26(10):1199-1202. PubMed ID: 32996387
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Specialty pharmacies and other restricted drug distribution systems: financial and safety considerations for patients and health-system pharmacists.
    Kirschenbaum BE
    Am J Health Syst Pharm; 2009 Dec; 66(24 Suppl 7):S13-20. PubMed ID: 19966075
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Milestones in managed care pharmacy.
    Cantrell S; Reilly C
    J Manag Care Spec Pharm; 2020 Nov; 26(11):1379-1383. PubMed ID: 33119449
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Moving Pharmacy Benefits from Nice to Have to Essential Benefits.
    Caldwell KA; Edgar B
    J Manag Care Spec Pharm; 2020 Aug; 26(8):943-944. PubMed ID: 32715963
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Letter--Draft FDA Guidance "Considerations in Demonstrating Interchangeability with a Reference Product": Overview and Presentation-Related Concerns.
    Rubinstein E
    J Manag Care Spec Pharm; 2017 Mar; 23(3):266. PubMed ID: 28230453
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FDA, states discuss pharmacy compounding regulatory framework.
    Traynor K
    Am J Health Syst Pharm; 2013 Feb; 70(3):180, 182. PubMed ID: 23327976
    [No Abstract]   [Full Text] [Related]  

  • 9. Toward permissionless innovation in health care.
    Adams AJ
    J Am Pharm Assoc (2003); 2015; 55(4):359-62. PubMed ID: 26161479
    [No Abstract]   [Full Text] [Related]  

  • 10. Specialty pharmacy management. Interview by Ian Morrison.
    Stern D
    Manag Care; 2007 Sep; 16(9 Suppl 9):28-30. PubMed ID: 17977130
    [No Abstract]   [Full Text] [Related]  

  • 11. Pharmacists want FDA to create new intermediate drug category.
    Traynor K
    Am J Health Syst Pharm; 2008 Jan; 65(1):10-4. PubMed ID: 18159029
    [No Abstract]   [Full Text] [Related]  

  • 12. Attention Turns to Specialty Pharmacy.
    Dross D
    Benefits Q; 2017; 33(2):12-15. PubMed ID: 29782733
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Emergence of Specialty Pharmacy.
    Vanscoy GJ
    J Manag Care Spec Pharm; 2020 Mar; 26(3):229-233. PubMed ID: 32105167
    [No Abstract]   [Full Text] [Related]  

  • 14. Lawmakers get big picture on pharmacy issues.
    Kertesz L
    AHIP Cover; 2008; 49(6):10, 67, 69. PubMed ID: 19180929
    [No Abstract]   [Full Text] [Related]  

  • 15. Improving and enforcing compounding pharmacy practices to protect patients.
    Pegues DA
    Clin Infect Dis; 2006 Oct; 43(7):838-40. PubMed ID: 16941363
    [No Abstract]   [Full Text] [Related]  

  • 16. Engineering new strategies in specialty pharmacy management.
    Edlin M
    AHIP Cover; 2004; 45(5):34-9. PubMed ID: 15499743
    [No Abstract]   [Full Text] [Related]  

  • 17. Application of a Graphical Depiction of Longitudinal Study Designs to Managed Care Pharmacy Research.
    Happe LE; Brown JD; Gatwood J; Schneeweiss S; Wang S
    J Manag Care Spec Pharm; 2020 Mar; 26(3):268-274. PubMed ID: 32105168
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmaceutical policy and the pharmacy profession.
    Traulsen JM; Almarsdóttir AB
    Pharm World Sci; 2005 Oct; 27(5):359-63. PubMed ID: 16341741
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Primer for Managed Care Residents: How to Conduct Research Using Live Medical and Pharmacy Claims Data.
    Hung A; Gedey R; Groeneweg M; Jay M
    J Manag Care Spec Pharm; 2019 May; 25(5):538-543. PubMed ID: 31039066
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adherence to oral oncolytics filled through an internal health-system specialty pharmacy compared with external specialty pharmacies.
    Academia EC; Mejías-De Jesús CM; Stevens JS; Jia LY; Yankama T; Patel C; Lee J
    J Manag Care Spec Pharm; 2021 Oct; 27(10):1438-1446. PubMed ID: 34595953
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.